Back to HALO Stock Lookup

HALO – Company Press Releases

Apr 9, 2014 08:00 AM Halozyme Announces Clinical Hold of PEGPH20 Pancreatic Cancer Trial Following Voluntary Halt of Trial by Halozyme
Apr 8, 2014 09:00 AM Halozyme Announces Preclinical Data Presentations At The Association Of Cancer Research Annual Meeting
Apr 4, 2014 08:00 AM Halozyme Announces Temporary Halt Of Phase 2 Trial Enrollment And Dosing For PEGPH20
Apr 2, 2014 08:00 AM Halozyme Announces Appointment Of Oncology Product Team Leader And Other Executive Transitions
Mar 31, 2014 08:00 AM Halozyme Announces that Consistent 1 Trial Of Hylenex® Recombinant Met Primary Endpoint
Mar 28, 2014 08:00 AM Halozyme Announces Roche Marketing Authorization For MabThera SC For Patients With Common Forms Of Non-Hodgkin Lymphoma In European Union
Mar 25, 2014 08:00 AM Halozyme Announces Positive Results From Phase 1/2 Clinical Trial In Cellulite With HTI-501
Mar 5, 2014 08:00 AM Halozyme Therapeutics To Present At The Barclays 2014 Global Healthcare Conference
Feb 27, 2014 04:15 PM Halozyme Reports Fourth Quarter And Year End 2013 Financial Results
Feb 25, 2014 04:15 PM Halozyme Therapeutics To Present At The Cowen And Company 34th Annual Healthcare Conference
Feb 20, 2014 04:30 PM Halozyme to Host Fourth Quarter and 2013 Year-End Financial Results Conference Call
Feb 10, 2014 04:15 PM Halozyme Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares
Feb 4, 2014 08:20 PM Halozyme Therapeutics Prices Public Offering Of Common Stock
Feb 3, 2014 04:01 PM Halozyme Therapeutics Announces Public Offering Of Common Stock
Jan 24, 2014 11:32 AM Halozyme Announces Positive Opinion From CHMP For European Approval Of Roche's MabThera SC

Back to HALO Stock Lookup